The role of SGLT2 inhibitors in CV risk reduction in patients with type 2 diabetes
1 September 2019 (13:05 - 13:20)
Organised by:
About the speaker
Cedars-Sinai Medical Centre, Los Angeles (United States of America)
4 More presentations in this session
Access the full session
The Event
ESC Congress 2019
1 September 2019
13:05 CET
